Cargando…

Is aberrant CD8+ T cell activation by hypertension associated with cardiac injury in severe cases of COVID-19?

Detalles Bibliográficos
Autores principales:	Zhang, Chao, Wang, Fu-Sheng, Silvestre, Jean-Sébastien, Arenzana-Seisdedos, Fernando, Tang, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214859/ https://www.ncbi.nlm.nih.gov/pubmed/32398804 http://dx.doi.org/10.1038/s41423-020-0454-3

Ejemplares similares

SDF-1/CXCL12: A Chemokine in the Life Cycle of HIV
por: Arenzana-Seisdedos, Fernando
Publicado: (2015)

Liver injury in COVID-19: management and challenges
por: Zhang, Chao, et al.
Publicado: (2020)

Recent insights into the crosstalk between senescent cells and CD8 T lymphocytes
por: Marin, Ines, et al.
Publicado: (2023)

Severe COVID-19 and preexisting hypertension: a matter of age?
por: Yamazaki, Osamu, et al.
Publicado: (2022)

The grace of aging with ART: Ex vivo dendritic cell-based immunotherapy restores HIV-specific functional CD8(+) T-cells
por: Mehraj, Vikram, et al.
Publicado: (2022)

Modeling Acute Pericarditis: An Inflammatory Step Toward Tailored Therapeutic Strategies
por: Silvestre, Jean-Sébastien
Publicado: (2021)

Comments to Article by Thoene M et al., Nutrients 2016, 8, 451
por: Moya, Fernando
Publicado: (2016)

Counting the costs of trauma: the need for a new paediatric injury severity score
por: Sargent, William, et al.
Publicado: (2021)

How to deal with hypertension in the COVID-19 era—the impact “ON” and “OF” hypertension
por: Ishida, Mari
Publicado: (2021)

What to do next to control the 2019-nCoV epidemic?
por: Wang, Fu-Sheng, et al.
Publicado: (2020)

COVID-19 in people with HIV
por: Xu, Zhe, et al.
Publicado: (2020)

Role of CD8 in Aberrant Function of Cytotoxic T Lymphocytes
por: Kessler, Benedikt, et al.
Publicado: (1997)

Are women with asthma at increased risk for severe COVID-19?
por: Fernando, Mario, et al.
Publicado: (2021)

COVID-19 and hypertension: risks and management. A scientific statement on behalf of the British and Irish Hypertension Society
por: Clark, Christopher E., et al.
Publicado: (2021)

CD56(dim)CD16(dim) Natural Killer (NK) Cells: The Forgotten Population
por: Zimmer, Jacques
Publicado: (2020)

Vitamin C for Cardiac Surgery Patients: Several Errors in a Published Meta-Analysis. Comment on “Effects of Vitamin C on Organ Function in Cardiac Surgery Patients: A Systematic Review and Meta-Analysis. Nutrients 2019, 11, 2103”
por: Hemilä, Harri, et al.
Publicado: (2020)

Fitness and reduced risk of hypertension—approaching causality
por: Laukkanen, Jari A., et al.
Publicado: (2021)

Resistant hypertension and COVID-19: tip of the iceberg?
por: Tadic, Marijana, et al.
Publicado: (2021)

Aberrant cytokine milieu and signaling affect immune cell phenotypes and functions in tuberculosis pathology: What can we learn from this phenomenon for application to inflammatory syndromes?
por: Adankwah, Ernest, et al.
Publicado: (2021)

COVID-19-related ARDS: one disease, two trajectories, and several unanswered questions
por: Lascarrou, Jean-Baptiste
Publicado: (2021)

Editorial: Inflammation and Reparative Process After Cardiac Injury
por: Silvestre, Jean-Sébastien, et al.
Publicado: (2019)

Severe COVID-19 in the young and healthy: monogenic inborn errors of immunity?
por: Zhang, Shen-Ying, et al.
Publicado: (2020)

Hypertension, renin–angiotensin–aldosterone system inhibition, and COVID-19
por: Williams, Bryan, et al.
Publicado: (2020)

Melatonin as a rational alternative in the conservative treatment of resistant hypertension
por: Simko, Fedor, et al.
Publicado: (2019)

CD24Fc: an emerging COVID-19 therapy
por: Eckhardt, Christina M, et al.
Publicado: (2022)

Revisiting the diagnosis of ‘resistant hypertension’: what should we do nowadays’
por: Alsharari, Reem, et al.
Publicado: (2021)

Hypertensive and cognitive function: did we come to a dead end?
por: Tadic, Marijana, et al.
Publicado: (2022)

Cardiac monoamine oxidases: at the heart of mitochondrial dysfunction
por: Mialet-Perez, Jeanne, et al.
Publicado: (2020)

Cutting the molecular brakes to achieve cardiac regeneration
por: Nelson, Victoria L., et al.
Publicado: (2021)

Out-of-hospital cardiac arrest: predict and then protect!
por: Spadafora, Luigi, et al.
Publicado: (2023)

Anxiety and hypertension in the COVID-19 era: how is the central autonomic network linked?
por: Nagai, Michiaki, et al.
Publicado: (2022)

Sudden death in a patient with epilepsy and arterial hypertension: time for re-assessment
por: Scorza, Fulvio A., et al.
Publicado: (2021)

Impact of the COVID-19 pandemic on physical and psychological activities in elderly patients with hypertension
por: Azushima, Kengo, et al.
Publicado: (2022)

Preliminary results of an ongoing multicentric prospective study on hypertensive emergencies and urgencies in Italy
por: Kotruchin, Praew
Publicado: (2023)

βIV-Spectrin in Cardiac Fibroblasts: Implications for Fibrosis and Therapeutic Targeting in Cardiac Diseases. Comment on Nassal et al. Spectrin-Based Regulation of Cardiac Fibroblast Cell-Cell Communication. Cells 2023, 12, 748
por: Xiang, Wenjing, et al.
Publicado: (2023)

SARS-CoV-2 infection and cardiac arrhythmias
por: Dewland, Thomas A., et al.
Publicado: (2022)

Azithromycin for severe COVID-19
por: Oldenburg, Catherine E, et al.
Publicado: (2020)

Omicron severity: milder but not mild
por: Nealon, Joshua, et al.
Publicado: (2022)

Measurement of blood pressure in the leg—a statement on behalf of the British and Irish Hypertension Society
por: Sheppard, James P., et al.
Publicado: (2020)

Why we need a single independent international hypertension clinical practice guideline
por: Ben-Eltriki, Mohamed, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_glkgp0iohlfrvv4ddt90dvo100